Microsoft word - prostate cancer press release 11 oct 2010.doc
Note: Data in this release correspond to ESMO abstract LBA5 EMBARGOED UNTIL Monday, 11 October 2010 at 2pm GMT Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer Results observed in patients treated with abiraterone acetate plus whose disease progressed after docetaxel-based chemotherapy Based on the results o